Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Report

Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major 40 Countries or Regions

  • POSTDATE：Apr 25, 2021
  • PAGES：147
  • REPORT CODE：GMM653651
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors is expected to grow from USD XX.0 million in 2018 to USD XX.0 million by 2025, at a Compound Annual Growth Rate (CAGR) of XX.0% during the forecast period. The research provides insights for the global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors market based on different Types, End-Users and Regions, and competitive landscape of these segments are analyzed in detail.

    A wide range of market influence factors are taken into consideration in the analysis, and potential developing factors for different Types, End-Users and Regions are also included in the report in order to figure out the most promising development trends in the Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors industry. For presenting the most potential investment fields in North America, Europe, Asia Pacific and Latin America, Middle East & Africa, the market capacity and consumption potential of more than 34 major powers are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Segmentations:

    By Players:

    • Bristol Myers Squibb

    • Boehringer Ingelheim

    • AstraZeneca

    • Eli Lilly

    • Kotobuki Pharmaceutical

    • Astellas

    • Janssen Pharmaceuticals

    By Types:

    • Invokana (Canagliflozin)

    • Jardiance (Empagliflozin)

    • Farxiga/Forxiga (Dapagliflozin)

    • Suglat (Ipragliflozin)

    By End-User:

    • Hospital

    • Medical Research Institute

    • Other

    By Regions:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • France

    • Italy

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

    • Spain

    • Belgium

    • Poland

    • Russia

    • Turkey

    • Others

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Australia and New Zealand

    • ASEAN Countries (Indonesia, Thailand, Malaysia, Singapore, Philippines, Vietnam, Others)

    Latin America, Middle East & Africa

    • GCC Countries (Saudi Arabia, United Arab Emirates, Qatar, Others)

    • Brazil

    • Nigeria

    • South Africa

    • Argentina

    • Others

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market

    • 1.3 Market Segmentation by Type

      • 1.3.1 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size and Growth Rate of Invokana (Canagliflozin) from 2014 to 2026

      • 1.3.2 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size and Growth Rate of Jardiance (Empagliflozin) from 2014 to 2026

      • 1.3.3 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size and Growth Rate of Farxiga/Forxiga (Dapagliflozin) from 2014 to 2026

      • 1.3.4 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size and Growth Rate of Suglat (Ipragliflozin) from 2014 to 2026

    • 1.4 Market Segmentation by End-Users

      • 1.4.1 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size and Growth Rate of Hospital from 2014 to 2026

      • 1.4.2 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size and Growth Rate of Medical Research Institute from 2014 to 2026

      • 1.4.3 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size and Growth Rate of Other from 2014 to 2026

    • 1.5 Market Segmentation by Regions

      • 1.5.1 North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.1 United States Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.2 Canada Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.3 Mexico Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.1 Germany Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.2 UK Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.3 France Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.4 Italy Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.5 Nordic Countries Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.6 Spain Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.7 Belgium Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.8 Poland Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.9 Russia Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.10 Turkey Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 Asia-Pacific Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.1 China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.2 Japan Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.3 Australia and New Zealand Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.4 India Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.5 ASEAN Countries Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.6 South Korea Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Latin America, Middle East & Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.1 GCC Countries Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.2 Brazil Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.3 Nigeria Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.4 South Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.5 Argentina Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints 

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market by Types

    • 3.1 Product Development Trends of Different Types

    • 3.2 Commercial Product Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors by Major Types

      • 3.4.1 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size and Growth Rate of Invokana (Canagliflozin)

      • 3.4.2 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size and Growth Rate of Jardiance (Empagliflozin)

      • 3.4.3 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size and Growth Rate of Farxiga/Forxiga (Dapagliflozin)

      • 3.4.4 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size and Growth Rate of Suglat (Ipragliflozin)

    4 Segmentation of Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors in Hospital

      • 4.4.2 Market Size and Growth Rate of Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors in Medical Research Institute

      • 4.4.3 Market Size and Growth Rate of Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors in Other

    5 Market Analysis by Major Regions

    • 5.1 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Production Analysis by Major Regions

    • 5.2 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumption Analysis by Major Regions

    • 5.3 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Production, Import, Consumption and Export Analysis 

      • 5.3.2 Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Production, Import, Consumption and Export Analysis

      • 5.3.3 Asia Pacific Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Production, Import, Consumption and Export Analysis

      • 5.3.4 Latin America, Middle East & Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Production, Import, Consumption and Export Analysis

    6 Product Commodity of Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market in Major Countries

    • 6.1 Top 5 Export Countries in Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries' Export Value Analysis in Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries'  Export Volume Analysis in Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries' Import Value Analysis in Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries' Import Volume Analysis in Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7 North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Landscape Analysis

    • 7.1 North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Landscape Analysis by Major Types

    • 7.2 North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Landscape Analysis by Major End-Users

    • 7.3 North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Landscape Analysis by Major Countries

      • 7.3.1 United States Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Volume and Growth Rate

      • 7.3.2 Canada Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Volume and Growth Rate

      • 7.3.3 Mexico Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Volume and Growth Rate

    8 Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Landscape Analysis

    • 8.1 Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Landscape Analysis by Major Types

    • 8.2 Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Landscape Analysis by Major End-Users

    • 8.3 Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Landscape Analysis by Major Countries

      • 8.3.1 Germany Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Volume and Growth Rate

      • 8.3.2 UK Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Volume and Growth Rate

      • 8.3.3 France Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Volume and Growth Rate

      • 8.3.4 Italy Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Volume and Growth Rate

      • 8.3.5 Nordic Countries Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Volume and Growth Rate

      • 8.3.6 Spain Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Volume and Growth Rate

      • 8.3.7 Belgium Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Volume and Growth Rate

      • 8.3.8 Poland Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Volume and Growth Rate

      • 8.3.9 Russia Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Volume and Growth Rate

      • 8.3.10 Turkey Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Volume and Growth Rate

    9 Asia Pacific Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Landscape Analysis

    • 9.1 Asia Pacific Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Landscape Analysis by Major Types

    • 9.2 Asia Pacific Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Landscape Analysis by Major End-Users

    • 9.3 Asia Pacific Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Landscape Analysis by Major Countries

      • 9.3.1 China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Volume and Growth Rate

      • 9.3.2 Japan Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Volume and Growth Rate

      • 9.3.3 Australia and New Zealand Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Volume and Growth Rate

      • 9.3.4 India Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Volume and Growth Rate

      • 9.3.5 ASEAN Countries Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Volume and Growth Rate

      • 9.3.6 South Korea Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Volume and Growth Rate

    10 Latin America, Middle East & Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Landscape Analysis

    • 10.1 Latin America, Middle East & Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Landscape Analysis by Major Types

    • 10.2 Latin America, Middle East & Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Landscape Analysis by Major End-Users

    • 10.3 Latin America, Middle East & Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Landscape Analysis by Major Countries

      • 10.3.1 GCC Countries Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Volume and Growth Rate

      • 10.3.2 Brazil Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Volume and Growth Rate

      • 10.3.3 Nigeria Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Volume and Growth Rate

      • 10.3.4 South Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Volume and Growth Rate 

      • 10.3.5 Argentina Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Volume and Growth Rate

    11 Major Players Profile

    • 11.1 Bristol Myers Squibb

      • 11.1.1 Bristol Myers Squibb Company Profile and Recent Development

      • 11.1.2 Market Performance

      • 11.1.3 Product and Service Introduction

    • 11.2 Boehringer Ingelheim

      • 11.2.1 Boehringer Ingelheim Company Profile and Recent Development

      • 11.2.2 Market Performance

      • 11.2.3 Product and Service Introduction

    • 11.3 AstraZeneca

      • 11.3.1 AstraZeneca Company Profile and Recent Development

      • 11.3.2 Market Performance

      • 11.3.3 Product and Service Introduction

    • 11.4 Eli Lilly

      • 11.4.1 Eli Lilly Company Profile and Recent Development

      • 11.4.2 Market Performance

      • 11.4.3 Product and Service Introduction

    • 11.5 Kotobuki Pharmaceutical

      • 11.5.1 Kotobuki Pharmaceutical Company Profile and Recent Development

      • 11.5.2 Market Performance

      • 11.5.3 Product and Service Introduction

    • 11.6 Astellas

      • 11.6.1 Astellas Company Profile and Recent Development

      • 11.6.2 Market Performance

      • 11.6.3 Product and Service Introduction

    • 11.7 Janssen Pharmaceuticals

      • 11.7.1 Janssen Pharmaceuticals Company Profile and Recent Development

      • 11.7.2 Market Performance

      • 11.7.3 Product and Service Introduction

    12 Data Source and Research Methodology

    The List of Tables and Figures (Totals 81 Figures and 165 Tables)

    • Figure Product Picture

    • Figure Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size and Growth Rate of Invokana (Canagliflozin) from 2014 to 2026

    • Figure Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size and Growth Rate of Jardiance (Empagliflozin) from 2014 to 2026

    • Figure Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size and Growth Rate of Farxiga/Forxiga (Dapagliflozin) from 2014 to 2026

    • Figure Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size and Growth Rate of Suglat (Ipragliflozin) from 2014 to 2026

    • Figure Market Share by Type in 2014

    • Figure Market Share by Type in 2018

    • Figure Market Share by Type in 2026

    • Figure Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size and Growth Rate of Hospital from 2014 to 2026

    • Figure Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size and Growth Rate of Medical Research Institute from 2014 to 2026

    • Figure Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size and Growth Rate of Other from 2014 to 2026

    • Figure Market Share by End-User in 2014

    • Figure Market Share by End-User in 2018

    • Figure Market Share by End-User in 2026

    • Figure North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure United States Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Germany Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure UK Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure France Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Asia-Pacific Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Japan Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Australia and New Zealand Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure India Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure ASEAN Countries Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure South Korea Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Latin America, Middle East & Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure GCC Countries Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Brazil Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Nigeria Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure South Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Argentina Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2018

    • Figure Market Share of TOP 5 Players in 2018

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors by Different Types from 2014 to 2026

    • Table Consumption Share of Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Invokana (Canagliflozin)

    • Figure Market Size and Growth Rate of Jardiance (Empagliflozin)

    • Figure Market Size and Growth Rate of Farxiga/Forxiga (Dapagliflozin)

    • Figure Market Size and Growth Rate of Suglat (Ipragliflozin)

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors by Different End-Users from 2014 to 2026

    • Table Consumption Share of Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Hospital

    • Figure Market Size and Growth Rate of Medical Research Institute

    • Figure Market Size and Growth Rate of Other

    • Table Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Production by Major Regions

    • Table Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Production Share by Major Regions

    • Figure Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Production Share by Major Regions in 2014

    • Figure Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Production Share by Major Regions in 2018

    • Figure Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Production Share by Major Regions in 2026

    • Table Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumption by Major Regions

    • Table Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumption Share by Major Regions

    • Figure Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumption Share by Major Regions in 2014

    • Figure Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumption Share by Major Regions in 2018

    • Figure Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumption Share by Major Regions in 2026

    • Table North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Production, Import, Consumption and Export Analysis

    • Table Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Production, Import, Consumption and Export Analysis

    • Table Asia Pacific Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Production, Import, Consumption and Export Analysis

    • Table Latin America, Middle East & Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumption by Types from 2014 to 2026

    • Table North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumption Share by Types from 2014 to 2026

    • Figure North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumption Share by Types in 2014

    • Figure North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumption Share by Types in 2018

    • Figure North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumption Share by Types in 2026

    • Table North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumption by End-Users from 2014 to 2026

    • Table North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumption Share by End-Users from 2014 to 2026

    • Figure North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumption Share by End-Users in 2014

    • Figure North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumption Share by End-Users in 2018

    • Figure North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumption Share by End-Users in 2026

    • Table North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumption by Major Countries from 2014 to 2026

    • Table North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumption Share by Major Countries from 2014 to 2026

    • Figure North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumption Share by Major Countries in 2014

    • Figure North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumption Share by Major Countries in 2018

    • Figure North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumption Share by Major Countries in 2026

    • Figure United States Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Volume and Growth Rate from 2014 to 2026

    • Figure Canada Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Volume and Growth Rate from 2014 to 2026

    • Figure Mexico Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Volume and Growth Rate from 2014 to 2026

    • Table Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumption by Types from 2014 to 2026

    • Table Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumption Share by Types from 2014 to 2026

    • Figure Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumption Share by Types in 2014

    • Figure Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumption Share by Types in 2018

    • Figure Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumption Share by Types in 2026

    • Table Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumption by End-Users from 2014 to 2026

    • Table Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumption Share by End-Users from 2014 to 2026

    • Figure Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumption Share by End-Users in 2014

    • Figure Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumption Share by End-Users in 2018

    • Figure Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumption Share by End-Users in 2026

    • Table Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumption by Major Countries from 2014 to 2026

    • Table Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumption Share by Major Countries from 2014 to 2026

    • Figure Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumption Share by Major Countries in 2014

    • Figure Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumption Share by Major Countries in 2018

    • Figure Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumption Share by Major Countries in 2026

    • Figure Germany Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Volume and Growth Rate from 2014 to 2026

    • Figure UK Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Volume and Growth Rate from 2014 to 2026

    • Figure France Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Volume and Growth Rate from 2014 to 2026

    • Figure Italy Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Volume and Growth Rate from 2014 to 2026

    • Figure Nordic Countries Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Volume and Growth Rate from 2014 to 2026

    • Figure Belgium Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Volume and Growth Rate from 2014 to 2026

    • Figure Poland Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Volume and Growth Rate from 2014 to 2026

    • Figure Russia Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Volume and Growth Rate from 2014 to 2026

    • Figure Turkey Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Volume and Growth Rate from 2014 to 2026

    • Table Asia Pacific Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumption by Types from 2014 to 2026

    • Table Asia Pacific Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumption Share by Types from 2014 to 2026

    • Figure Asia Pacific Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumption Share by Types in 2014

    • Figure Asia Pacific Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumption Share by Types in 2018

    • Figure Asia Pacific Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumption Share by Types in 2026

    • Table Asia Pacific Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumption by End-Users from 2014 to 2026

    • Table Asia Pacific Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumption Share by End-Users from 2014 to 2026

    • Figure Asia Pacific Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumption Share by End-Users in 2014

    • Figure Asia Pacific Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumption Share by End-Users in 2018

    • Figure Asia Pacific Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumption Share by End-Users in 2026

    • Table Asia Pacific Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumption by Major Countries from 2014 to 2026

    • Table Asia Pacific Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumption Share by Major Countries from 2014 to 2026

    • Figure Asia Pacific Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumption Share by Major Countries in 2014

    • Figure Asia Pacific Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumption Share by Major Countries in 2018

    • Figure Asia Pacific Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumption Share by Major Countries in 2026

    • Figure China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Volume and Growth Rate from 2014 to 2026

    • Figure Japan Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Volume and Growth Rate from 2014 to 2026

    • Figure Australia and New ZealandSodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Volume and Growth Rate from 2014 to 2026

    • Figure India Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Volume and Growth Rate from 2014 to 2026

    • Figure ASEAN Countries Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Volume and Growth Rate from 2014 to 2026

    • Figure South Korea Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Volume and Growth Rate from 2014 to 2026

    • Table Latin America, Middle East & Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumption by Types from 2014 to 2026

    • Table Latin America, Middle East & Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumption Share by Types from 2014 to 2026

    • Figure Latin America, Middle East & Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumption Share by Types in 2014

    • Figure Latin America, Middle East & Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumption Share by Types in 2018

    • Figure Latin America, Middle East & Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumption Share by Types in 2026

    • Table Latin America, Middle East & Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumption by End-Users from 2014 to 2026

    • Table Latin America, Middle East & Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumption Share by End-Users from 2014 to 2026

    • Figure Latin America, Middle East & Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumption Share by End-Users in 2014

    • Figure Latin America, Middle East & Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumption Share by End-Users in 2018

    • Figure Latin America, Middle East & Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumption Share by End-Users in 2026

    • Table Latin America, Middle East & Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumption by Major Countries from 2014 to 2026

    • Table Latin America, Middle East & Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumption Share by Major Countries from 2014 to 2026

    • Figure Latin America, Middle East & Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumption Share by Major Countries in 2014

    • Figure Latin America, Middle East & Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumption Share by Major Countries in 2018

    • Figure Latin America, Middle East & Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumption Share by Major Countries in 2026

    • Figure GCC Countries Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Volume and Growth Rate from 2014 to 2026

    • Figure Brazil Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Volume and Growth Rate from 2014 to 2026

    • Figure Nigeria Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Volume and Growth Rate from 2014 to 2026

    • Figure South Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Volume and Growth Rate from 2014 to 2026

    • Figure Argentina Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of Bristol Myers Squibb

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bristol Myers Squibb

    • Figure Sales and Growth Rate Analysis of Bristol Myers Squibb

    • Figure Revenue and Market Share Analysis of Bristol Myers Squibb

    • Table Product and Service Introduction of Bristol Myers Squibb

    • Table Company Profile and Development Status of Boehringer Ingelheim

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Boehringer Ingelheim

    • Figure Sales and Growth Rate Analysis of Boehringer Ingelheim

    • Figure Revenue and Market Share Analysis of Boehringer Ingelheim

    • Table Product and Service Introduction of Boehringer Ingelheim

    • Table Company Profile and Development Status of AstraZeneca

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of AstraZeneca

    • Figure Sales and Growth Rate Analysis of AstraZeneca

    • Figure Revenue and Market Share Analysis of AstraZeneca

    • Table Product and Service Introduction of AstraZeneca

    • Table Company Profile and Development Status of Eli Lilly

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eli Lilly

    • Figure Sales and Growth Rate Analysis of Eli Lilly

    • Figure Revenue and Market Share Analysis of Eli Lilly

    • Table Product and Service Introduction of Eli Lilly

    • Table Company Profile and Development Status of Kotobuki Pharmaceutical

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Kotobuki Pharmaceutical

    • Figure Sales and Growth Rate Analysis of Kotobuki Pharmaceutical

    • Figure Revenue and Market Share Analysis of Kotobuki Pharmaceutical

    • Table Product and Service Introduction of Kotobuki Pharmaceutical

    • Table Company Profile and Development Status of Astellas

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Astellas

    • Figure Sales and Growth Rate Analysis of Astellas

    • Figure Revenue and Market Share Analysis of Astellas

    • Table Product and Service Introduction of Astellas

    • Table Company Profile and Development Status of Janssen Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Janssen Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Janssen Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Janssen Pharmaceuticals

    • Table Product and Service Introduction of Janssen Pharmaceuticals


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US